docetaxel anhydrous has been researched along with maleimide in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (maleimide) | Trials (maleimide) | Recent Studies (post-2010) (maleimide) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 793 | 2 | 487 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | maleimide (IC50) |
|---|---|---|---|
| [tau protein] kinase | Oryctolagus cuniculus (rabbit) | 6 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 6 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, YW; Goh, MS; Kang, MJ; Kim, CH; Lee, ES; Lee, S; Lee, SG; Sung, SW; Yoon, HY | 1 |
1 other study(ies) available for docetaxel anhydrous and maleimide
| Article | Year |
|---|---|
RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Humans; Hydrophobic and Hydrophilic Interactions; Lipids; Maleimides; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Particle Size; Peptides; Serine Endopeptidases; Taxoids; Xenograft Model Antitumor Assays | 2018 |